News | Coronavirus (COVID-19) | October 11, 2023

Unvaccinated Covid-19 Survivors Face Higher Risk of Heart Complications, Singapore Study Finds

Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later

Getty Images


October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later, a national study led by Nanyang Technological University, Singapore (NTU Singapore) and affiliated faculty has found. 

The study, based on testing and medical claims records of 106,012 people resident in Singapore and diagnosed with COVID-19 between 1 September and 31 November 2021, was during the period of the Delta variant predominance. The study found that many (912 patients) who have recovered from COVID-19 have reported lingering after-effects, consistent with the ‘long Covid’ syndrome. These may include symptoms of fatigue, shortness of breath, problems with memory, and heart complications like cardiovascular, cerebrovascular and thrombosis. 

This COVID-19 positive group was compared with a group of nearly 1.7 million in the community who were not known to be infected with the virus during that time. Both groups were tracked over an average period of 300 days, looking at whether they developed ‘long Covid’ syndrome and, specifically, heart complications. 

The study, published in Clinical Infectious Diseases in September, is the first and largest to examine the risk of long COVID-19 in a highly vaccinated, multi-ethnic Southeast Asian population. 

The study was carried out by researchers from NTU’s Lee Kong Chian School of Medicine (LKCMedicine), Ministry of Health, SingaporeSingapore General Hospital, and National Centre for Infectious Diseases, Singapore. 

It is supported by the Programme for Research in Epidemic Preparedness and Response (PREPARE), a national initiative by the Ministry of Health to support and strengthen Singapore’s key essential research capabilities, translational platforms, and expertise to develop tools, methods and products that can be tapped on to detect, respond to, and contain future infectious disease threats. 

Lead author of the study, Assistant Professor Lim Jue Tao, Infectious Disease Modelling at LKCMedicine, said, “We were motivated to conduct our study after hearing of increasing reports of long Covid syndrome. Even though we are now in the post-pandemic period, our findings remain relevant as COVID is here to stay with evolving variants, and the world will continue to need to understand its effects and safeguard ourselves. Our study underscores the need for people to get vaccinated and boosted as a vital means of protection.” 

Infected but unvaccinated individuals face a 56 per cent higher risk of heart complications post COVID-19 

The researchers’ statistical analysis of their data found that unvaccinated survivors of COVID-19 face a 56 per cent higher risk of developing new heart complications a year following the infection than uninfected individuals. For example, the study observed that 311 people or 0.297 per cent (vs test-negative group of 3071 people or 0.184 per cent), who did not have dysrhythmias, or abnormal heartbeat, prior to infection developed dysrhythmias a year following the infection than uninfected individuals. 

Risk refers to the percentage chance of developing a specified heart complication in the 300 days following testing positive or negative for COVID-19. 

In separate analyses comparing boosted, vaccinated, and unvaccinated COVID-19 survivors and the uninfected group, the research team also found that risk was lowered when individuals were vaccinated or boosted. Vaccinated COVID-19 survivors had an 11 per cent risk of heart complications versus uninfected individuals, while boosted COVID-19 survivors had the same risk of heart complications when compared with uninfected individuals. The findings show the importance of vaccination and boosting to attenuate potential complications of long Covid. 

Commenting as an independent expert, Associate Professor Alex Cook, Vice Dean (Research), Saw Swee Hock School of Public Health, National University of Singapore, said, “This is an important study that sheds new light on the under-studied issue of long Covid in Singapore. Although the COVID-19 pandemic may be past, COVID-19 as an illness remains with us, and the NTU-led study re-emphasises the need to stay up to date with your COVID-19 boosters.” 

The researchers noted that there are limitations to the study. The uninfected group tracked in the analysis includes those who were asymptomatic or did not seek medical care, which may have led to misclassification. Individual health measurements such as blood pressure and body mass index, which are associated with the risk of heart complications, were not considered. 

In future research, the team of researchers will be looking at neuropsychiatric and respiratory complications and the effect of long Covid on healthcare utilisation. 

For more information: https://www.ntu.edu.sg/ 

 

Related Long-COVID Coverage:   

ACC23 Study Finds Long COVID More Than Doubles Risk of Developing New Cardiac Symptoms   

ACC Scientific Session 2023 to Feature Smidt Heart Institute Experts   

The Effects of Long COVID   

MRI Sheds Light on COVID Vaccine-Associated Heart Muscle Injury    

What We Know About Cardiac Long-COVID Two Years Into the Pandemic     

VIDEO: Long-term Cardiac Impacts of COVID-19 Two Years Into The Pandemic — Interview with Aaron Baggish, M.D.    

VIDEO: Long-COVID Presentations in Cardiology at Beaumont Hospital — Interview with Justin Trivax, M.D.    

VIDEO: Cardiac Presentations in COVID Long-haulers at Cedars-Sinai Hospital — Interview with Siddharth Singh, M.D.    

Find more COVID news and videos    


Related Content

News | Heart Failure

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
News | Heart Failure

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million ...

Home June 07, 2024
Home
News | Heart Failure

June 7, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home June 07, 2024
Home
News | Heart Failure

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
Subscribe Now